|Bid||0.00 x 1000|
|Ask||0.00 x 800|
|Day's Range||144.93 - 147.21|
|52 Week Range||98.23 - 160.25|
|Beta (3Y Monthly)||1.29|
|PE Ratio (TTM)||41.79|
|Earnings Date||Oct 30, 2019|
|Forward Dividend & Yield||N/A (N/A)|
|1y Target Est||173.00|
HMS Holdings (HMSY) is gaining traction from growing PI and TPM analytical services as well as robust margins despite intense competition.
We've lost count of how many times insiders have accumulated shares in a company that goes on to improve markedly. On...
The collaboration with GetWellNetwork is likely to allow Cerner (CERN) in enhancing functionality for clients and patients through third-party solutions.
Masimo announced today that in a study published in Injury, researchers used Masimo SpHb® – noninvasive, continuous hemoglobin monitoring – to investigate possible delays in the detection of perioperative anemia assessed using invasive, intermittent laboratory hemoglobin values in elderly patients undergoing hip fracture surgery.1 In addition, they investigated associations between a) this delay and ...
With these additions, clinicians will now be able to view the relative contribution of each component to a patient’s overall rSO2. O3, available on the Masimo Root® Patient Monitoring and Connectivity Platform, is FDA cleared for the monitoring of cerebral oxygenation and may be helpful in situations in which peripheral pulse oximetry alone may not be fully indicative of the oxygenation of the brain. O3 uses near-infrared spectroscopy (NIRS) to monitor and display continuous rSO2 values for each side of the brain.
Shares of medical stocks Idexx Laboratories and Masimo approached breakouts Friday as Wall Street enjoyed a third day of gains. Both stocks are now in the process of forming flat bases.
Masimo's (MASI) new feature, Pathway, is likely to help clinicians simplify their workflow associated with newborn resuscitation, thereby improving patient monitoring.
Masimo today announced that its management is scheduled to present at the Morgan Stanley 17th Annual Global Healthcare Conference at the Grand Hyatt New York on Tuesday, September 10, 2019 at 3:30 p.m.
Masimo today announced Pathway™, a feature for the Root® Patient Monitoring and Connectivity Platform. Pathway provides clinicians with a way to visualize a hospital’s recommended resuscitation protocol for a newborn’s oxygen saturation while continuously monitoring SpO2 and pulse rate during the first ten minutes after birth.